263 related articles for article (PubMed ID: 8996503)
1. Ventricular dilatation in experimental intraventricular hemorrhage in pigs. Characterization of cerebrospinal fluid dynamics and the effects of fibrinolytic treatment.
Mayfrank L; Kissler J; Raoofi R; Delsing P; Weis J; Küker W; Gilsbach JM
Stroke; 1997 Jan; 28(1):141-8. PubMed ID: 8996503
[TBL] [Abstract][Full Text] [Related]
2. Morphological changes following experimental intraventricular haemorrhage and intraventricular fibrinolytic treatment with recombinant tissue plasminogen activator.
Mayfrank L; Kim Y; Kissler J; Delsing P; Gilsbach JM; Schröder JM; Weis J
Acta Neuropathol; 2000 Nov; 100(5):561-7. PubMed ID: 11045679
[TBL] [Abstract][Full Text] [Related]
3. Lysis of intraventricular blood clot with urokinase in a canine model: Part 3. Effects of intraventricular urokinase on clot lysis and posthemorrhagic hydrocephalus.
Pang D; Sclabassi RJ; Horton JA
Neurosurgery; 1986 Oct; 19(4):553-72. PubMed ID: 3491340
[TBL] [Abstract][Full Text] [Related]
4. [Effectiveness and safety of intraventricular fibrinolysis in secondary intraventricular hemorrhages (a prospective, randomized study)].
Gubucz I; Kakuk I; Major O; Szegedi N; Barsi P; Pánczél G; Varga D; Ovary C; May Z; Ricsói G; Kenéz J; Szilágyi G; Nagy Z
Orv Hetil; 2004 Aug; 145(31):1609-15. PubMed ID: 15384858
[TBL] [Abstract][Full Text] [Related]
5. No exacerbation of perihematomal edema with intraventricular tissue plasminogen activator in patients with spontaneous intraventricular hemorrhage.
Ziai W; Moullaali T; Nekoovaght-Tak S; Ullman N; Brooks JS; Morgan TC; Hanley DF
Neurocrit Care; 2013 Jun; 18(3):354-61. PubMed ID: 23463422
[TBL] [Abstract][Full Text] [Related]
6. Fibrinolytic therapy in intraventricular hemorrhage.
Andrews CO; Engelhard HH
Ann Pharmacother; 2001 Nov; 35(11):1435-48. PubMed ID: 11724097
[TBL] [Abstract][Full Text] [Related]
7. Application of the Ommaya Reservoir in Managing Ventricular Hemorrhage.
Yang XT; Feng DF; Zhao L; Sun ZL; Zhao G
World Neurosurg; 2016 May; 89():93-100. PubMed ID: 26724628
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics and Pharmacodynamics of Tissue Plasminogen Activator Administered Through an External Ventricular Drain.
Kramer AH; Jenne C; Holodinsky JK; Todd S; Roberts DJ; Kubes P; Zygun DA; Hill MD; Leger C; Wong JH
Neurocrit Care; 2015 Dec; 23(3):386-93. PubMed ID: 25739904
[TBL] [Abstract][Full Text] [Related]
9. Treatment of intraventricular hemorrhage with urokinase : effects on 30-Day survival.
Naff NJ; Carhuapoma JR; Williams MA; Bhardwaj A; Ulatowski JA; Bederson J; Bullock R; Schmutzhard E; Pfausler B; Keyl PM; Tuhrim S; Hanley DF
Stroke; 2000 Apr; 31(4):841-7. PubMed ID: 10753985
[TBL] [Abstract][Full Text] [Related]
10. A multicenter, randomized, double-blinded, placebo-controlled phase III study of Clot Lysis Evaluation of Accelerated Resolution of Intraventricular Hemorrhage (CLEAR III).
Ziai WC; Tuhrim S; Lane K; McBee N; Lees K; Dawson J; Butcher K; Vespa P; Wright DW; Keyl PM; Mendelow AD; Kase C; Wijman C; Lapointe M; John S; Thompson R; Thompson C; Mayo S; Reilly P; Janis S; Awad I; Hanley DF;
Int J Stroke; 2014 Jun; 9(4):536-42. PubMed ID: 24033910
[TBL] [Abstract][Full Text] [Related]
11. Treatment of intraventricular hemorrhage using urokinase.
Shen PH; Matsuoka Y; Kawajiri K; Kanai M; Hoda K; Yamamoto S; Nishimura S
Neurol Med Chir (Tokyo); 1990 May; 30(5):329-33. PubMed ID: 1699149
[TBL] [Abstract][Full Text] [Related]
12. Effect of recombinant tissue plasminogen activator on clot lysis and ventricular dilatation in the treatment of severe intraventricular haemorrhage.
Mayfrank L; Lippitz B; Groth M; Bertalanffy H; Gilsbach JM
Acta Neurochir (Wien); 1993; 122(1-2):32-8. PubMed ID: 8333306
[TBL] [Abstract][Full Text] [Related]
13. Phase I study of intraventricular recombinant tissue plasminogen activator for treatment of posthaemorrhagic hydrocephalus.
Whitelaw A; Saliba E; Fellman V; Mowinckel MC; Acolet D; Marlow N
Arch Dis Child Fetal Neonatal Ed; 1996 Jul; 75(1):F20-6. PubMed ID: 8795351
[TBL] [Abstract][Full Text] [Related]
14. Tissue plasminogen activator for the treatment of intraventricular hematoma: the dose-effect relationship.
Wang YC; Lin CW; Shen CC; Lai SC; Kuo JS
J Neurol Sci; 2002 Oct; 202(1-2):35-41. PubMed ID: 12220690
[TBL] [Abstract][Full Text] [Related]
15. Recombinant tissue plasminogen activator for the treatment of spontaneous adult intraventricular hemorrhage.
Goh KY; Poon WS
Surg Neurol; 1998 Dec; 50(6):526-31; discussion 531-2. PubMed ID: 9870812
[TBL] [Abstract][Full Text] [Related]
16. Prognostic significance of third ventricle blood volume in intracerebral haemorrhage with severe ventricular involvement.
Staykov D; Volbers B; Wagner I; Huttner HB; Doerfler A; Schwab S; Bardutzky J
J Neurol Neurosurg Psychiatry; 2011 Nov; 82(11):1260-3. PubMed ID: 21515556
[TBL] [Abstract][Full Text] [Related]
17. Low levels of plasminogen in cerebrospinal fluid after intraventricular haemorrhage: a limiting factor for clot lysis?
Whitelaw A; Mowinckel MC; Abildgaard U
Acta Paediatr; 1995 Aug; 84(8):933-6. PubMed ID: 7488820
[TBL] [Abstract][Full Text] [Related]
18. Resolution of intraventricular hemorrhage varies by ventricular region and dose of intraventricular thrombolytic: the Clot Lysis: Evaluating Accelerated Resolution of IVH (CLEAR IVH) program.
Webb AJ; Ullman NL; Mann S; Muschelli J; Awad IA; Hanley DF
Stroke; 2012 Jun; 43(6):1666-8. PubMed ID: 22474059
[TBL] [Abstract][Full Text] [Related]
19. Urokinase versus Alteplase for intraventricular hemorrhage fibrinolysis.
Gaberel T; Montagne A; Lesept F; Gauberti M; Lemarchand E; Orset C; Goulay R; Bertrand T; Emery E; Vivien D
Neuropharmacology; 2014 Oct; 85():158-65. PubMed ID: 24846802
[TBL] [Abstract][Full Text] [Related]
20. Preliminary report of the clot lysis evaluating accelerated resolution of intraventricular hemorrhage (CLEAR-IVH) clinical trial.
Morgan T; Awad I; Keyl P; Lane K; Hanley D
Acta Neurochir Suppl; 2008; 105():217-20. PubMed ID: 19066112
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
